For Eacobacci, the insurance changes and the sentiment behind them are enraging and based in prejudice
How Menopause and Rapid Weight Loss May Affect Bone Density and Long-Term Strength This may be one of the most important conversations in the entire GLP-1 discussion for menopausal women
Introduction The rapid adoption of GLP-1 weight-loss medications such as Ozempic, Wegovy, and Mounjaro is reshaping consumer eating behavior these drugs are increasingly used not only for diabetes management but also for appetite and weight control, influencing how people select, consume, and prioritize food
The mechanism likely stems from biomechanical shifts and inadequate core adaptation rather than direct drug toxicity
The active ingredients in those drugs also are approved for other conditions, including diabetes and cardiovascular disease, that Medicare does cover